Rchr
J-GLOBAL ID:202101000916380120
Update date: Feb. 10, 2025 SASAKI-TANAKA Reina
タナカ(ササキ) レイナ | SASAKI-TANAKA Reina
Affiliation and department: Job title:
Associate Professor/Lecture
Homepage URL (1): https://www.med.niigata-u.ac.jp/in3/about/staff.html Research field (1):
Gastroenterology
Research theme for competitive and other funds (1): - 2023 - 2026 肝炎の重症化に関与するマイクロRNAの検討
Papers (95): -
Tatsuo Kanda, Reina Sasaki-Tanaka, Shuji Terai. Combination therapies with immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma with major vascular invasion. Hepatology International. 2025
-
Tatsuo Kanda, Reina Sasaki-Tanaka, Atsunori Tsuchiya, Shuji Terai. Hepatitis B virus infection and its treatment in Eastern Ethiopia. World Journal of Hepatology. 2025. 17. 1
-
Tatsuo Kanda, Reina Sasaki-Tanaka, Shuji Terai. Inflammation of the liver, HCC development and HCC establishment. Hepatology International. 2024
-
Tatsuo Kanda, Tian-Cheng Li, Masaharu Takahashi, Shigeo Nagashima, Putu Prathiwi Primadharsini, Satoshi Kunita, Reina Sasaki-Tanaka, Jun Inoue, Atsunori Tsuchiya, Shingo Nakamoto, et al. Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
-
Tatsuo Kanda, Reina Sasaki-Tanaka, Shuji Terai. Liver Diseases: From Bench to Bedside. International Journal of Molecular Sciences. 2024. 25. 10. 5454
more... MISC (3): -
Tatsuo Kanda, Shingo Nakamoto, Reina Sasaki, Yuki Haga, Masato Nakamura, Shin Yasui, Makoto Arai, Fumio Imazeki, Osamu Yokosuka. Assessment of serum hepatitis C virus RNA 24 weeks after the end of treatment using TaqMan PCR is more relevant than after 12 weeks for predicting sustained virological response by simeprevir-versus telaprevir-based triple therapy. HEPATOLOGY. 2015. 62. 807A-807A
-
Tatsuo Kanda, Shingo Nakamoto, Reina Sasaki, Yuki Haga, Masato Nakamura, Shin Yasui, Makoto Arai, Fumio Imazeki, Osamu Yokosuka. Assessment of serum hepatitis C virus RNA 24 weeks after the end of treatment using TaqMan PCR is more relevant than after 12 weeks for predicting sustained virological response by simeprevir-versus telaprevir-based triple therapy. HEPATOLOGY. 2015. 62. 807A-807A
-
Xia Jiang, Tatsuo Kanda, Shuang Wu, Yuki Haga, Reina Sasaki, Masato Nakamura, Shingo Nakamoto, Fumio Imazeki, Osamu Yokosuka. HCV NS5A blocks MG132-induced apoptosis in hepatocytes through the inhibition of NF-kappa B activation. HEPATOLOGY. 2014. 60. 647A-647A
Professional career (1): - Doctor of philosophy(Medicine) (Chiba University)
Return to Previous Page